Soleno Therapeutics to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will participate in the following upcoming investor conferences: Event: Jefferies Global Healthcare Conference Day: Wednesday, June 5, 2024 Time: 11:30 AM Eastern Time Event: Goldman Sachs 45th Annual Global Healthcare Confere ...